Overall, the findings demonstrate for the first time that MPP treats obesity by alleviating dyslipidemia, improving insulin resistance, and regulating gut microbiota to improve the intestinal environment. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.